Ernest Gervino, ScD

Dr. Gervino has trained generations of physicians, medical students and allied health professionals in the field of stress testing. Many have become leaders at regional, national and international levels. Accomplished physicians and health care professionals have done sabbaticals in my lab refining their skills in stress testing of high risk patients. I repeatedly give lectures on stress testing to house staff and attending physicians. I have developed the “BI Modified Bruce & Gervino Protocols” for patients with limited functional capacity; allowing for appropriate titration of physiologic responses prior to the patient reaching their functional limitations. In recognition of my expertise in the area of stress testing complex patients, I served on an AHA/ACC committee with a group of prestigious cardiologists as the only non-physician on “Who is competent to perform cardiac stress testing”. I also served on other national and regional committees and at our institution helping to set policy regarding stress testing.

My stress protocols have been used in national and international clinical research trials which include BiosenseDMR Angiogenesis National Project, Chiron FGF0002 Angiogenesis National Trial, Biosense DIRECT Angiogenesis National-International Project, Cardiac Dimension AMADEUS, COMPETENT, TITAN CVP-0855-01 National-International Trials and Baxter Autologous ACT CD34+ Cells National Trial.

I have performed Cardiopulmonary Stress Tests for the past 40 years on thousands of healthy and diseased patients to determine their metabolic response to exercise. I have also served as a peer reviewer for Harvard Catalyst Clinical & Translational Science Center as Scientific & Resource Reviewer on adult cardiology and the Core Lab Director for stress testing at Harvard Clinical Research Institute evaluating outcomes of clinical trials. I have collaborated in multi-centered national and international trials in cardiology, neurology and diabetes. I am consulted by industry as an expert in presentations to FDA panels based on clinical stress test results.

Baim- and Baim-affiliated faculty members disclose the conflicts of interest for the Baim Institute which can be viewed here.